Speaker(s): 

Anna Walton, CRNA, Staff Member, Geisinger - has nothing to disclose.

Kaylene Sutkowski, CRNA, Staff Member, Geisinger - has nothing to disclose. 

Moderator(s): 

Kristy Voytek, MD, Regional Chief of Anesthesia, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

•       Discuss the challenges of fear, stress, and anxiety experienced by pediatric patients undergoing surgical procedures
• Define the pediatric emergence agitation     
• Compare the mechanism of action of oral midazolam versus intranasal dexmedetomidine
• Discuss additional benefits and limitations of administering oral midazolam versus intranasal dexmedetomidine to pediatric patients
• Compare the amount of parent separation anxiety and emergence agitation in pediatric patients receiving oral midazolam versus intranasal dexmedetomidine
• Discuss the overall effect of oral midazolam and intranasal dexmedetomidine on the reduction in MAP and HR 

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Kristy Voytek, MD, Maria Mcgraw, CRNA, and Gary Sebastianelli, CRNA have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None.